This document is an excerpt from the EUR-Lex website
Document 62021TN0543
Case T-543/21: Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)
Case T-543/21: Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)
Case T-543/21: Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)
OJ C 422, 18.10.2021, p. 34–34
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
18.10.2021 |
EN |
Official Journal of the European Union |
C 422/34 |
Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)
(Case T-543/21)
(2021/C 422/44)
Language of the case: English
Parties
Applicant: Purasac Co. Ltd (Anyang-si, Republic of Korea) (represented by: P. Lee, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Prollenium Medical Technologies, Inc. (Aurora, Ontario, Canada)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union figurative mark Rejeunesse — Application for registration No 18 117 313
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 2 July 2021 in Case R 146/2021-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in the erroneous assessment of the likelihood of confusion between the trade marks. |